Chimeric Antigen Receptor T-cell Therapy
Mar 19, 2020
Multiple myeloma cancers arise from plasma cells in the blood and are the second-most common blood-related malignant cancer. There is currently no cure, but one of the promising treatments being developed comes from immunology - Chimeric Antigen Receptor T-cell therapy, or CAR-T.
Recommendation for you
-
Recommendation
Autophobia
Romance 1m likes
-
Recommendation
Copper eyes
BL 1.1m likes
-
Recommendation
Humor me
Slice of life 3.2m likes
-
Recommendation
Strange and Wild
Fantasy 831.4k likes
-
Recommendation
Domino Tower
BL 105.1k likes
-
Recommendation
Punderworld
Romance Fantasy 158.9k likes
-
Feeling lucky
Random series you may like
Cancer Decoded: Spotlight
5.5k views5 subscribers
Finding a cure for cancer has become a rallying cry for researchers, policy makers, and those affected by the condition. This series sifts through the pool of incremental advances to feature promising, novel ideas for therapies. Presented without the confusing terminology of research papers, let our adorable mascots highlight for you the ideas that have the potential to revolutionize healthcare.
Cancer Decoded is split into two series: The "Basics" series focuses on the fundamentals of cancer, whereas the "Spotlight" serieslooks at advanced, one-off, topics in cancer: like the HPV vaccine and cancer.
Cancer Decoded is split into two series: The "Basics" series focuses on the fundamentals of cancer, whereas the "Spotlight" serieslooks at advanced, one-off, topics in cancer: like the HPV vaccine and cancer.
Comments (0)
See all